The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 03, 2016
Filed:
Dec. 02, 2013
Pfizer Inc., New York, NY (US);
James Thomas Anderson, Hillsdale, NJ (US);
Eugene Lvovich Piatnitski Chekler, Concord, MA (US);
Edmund L. Ellsworth, Vicksburg, MI (US);
Bruce Kipp Erickson, Kalamazoo, MI (US);
Adam Matthew Gilbert, Guilford, CT (US);
Anthony P. Ricketts, Kalamazoo, MI (US);
David P. Thompson, Battle Creek, MI (US);
Rayomand Jal Unwalla, Bedford, MA (US);
Patrick Robert Verhoest, Newton, MA (US);
Pfizer Inc., New York, NY (US);
Abstract
The present invention relates to a compound of Formula 1, 2 or 3: wherein A is N or —CR—, where Ris hydrogen, C-Clinear or branched chain alkyl, etc., Z is —CR—, or, —N—, where Ris hydrogen, C-Clinear or branched chain alkyl, etc.; Ris hydrogen, C-Clinear or branched chain alkyl, etc.; Rare independently hydrogen or C-Clinear or branched chain alkyl; Rand Rare independently hydrogen, C-Clinear or branched chain alkyl, etc.; Rand Rare independently hydrogen or C-Clinear or branched chain alkyl, etc.; Ris hydrogen, C-Clinear or branched chain alkyl, etc.; Rand Rare independently hydrogen or C-Clinear or branched chain alkyl, etc.; Q is —CO—, —(CH)—, —(CHR)—, or —(CRR)—, where Rand Rare independently C-Clinear or branched chain alkyl, aryl, alkylaryl, heteroaryl or alkylheteroaryl; where q is 0, 1, 2, or 3; and, where n is 0, 1, 2, 3, 4 or 5; or, a pharmaceutically acceptable salt thereof, to compositions containing such compounds; and to the uses of such compounds in the treatment of various diseases, particularly, those affected or mediated by the androgen receptor.